|
Re: need more time, money & partners - FDA response may take until spring - pre market bid/ask..
|
1
|
Resverlogix Corp.
|
Dec 06, 2019 10:49AM
|
|
Financing
|
1
|
Resverlogix Corp.
|
Apr 26, 2024 11:18AM
|
|
Re: Update
|
1
|
Resverlogix Corp.
|
Feb 16, 2018 12:30PM
|
|
Re: Bloom Burton & Co Healthcare Conference
|
1
|
Resverlogix Corp.
|
Apr 19, 2018 04:03PM
|
|
Re: Seeing this kind of trading....
|
1
|
Resverlogix Corp.
|
Jul 17, 2015 08:03AM
|
|
Re: A bit of DD.
|
1
|
Resverlogix Corp.
|
Dec 10, 2021 01:08PM
|
|
Re: Resverlogix NYAS Symposium notes
|
1
|
Resverlogix Corp.
|
Apr 30, 2016 09:36AM
|
|
Re: Zenith prezzy
|
1
|
Zenith Epigenetics
|
Jun 21, 2017 12:55PM
|
|
Re: MERCK….
|
1
|
Resverlogix Corp.
|
Oct 02, 2021 10:47AM
|
|
Re: What Jardiance/EMPA-REG Outcome means for RVX-208
|
1
|
Resverlogix Corp.
|
Sep 17, 2015 03:28PM
|
|
Re: AGM - Jan 7, 2016 - Details
|
1
|
Zenith Epigenetics
|
Jan 14, 2016 10:03AM
|
|
Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
|
1
|
Resverlogix Corp.
|
Dec 05, 2017 05:46PM
|
|
Re: Share price - some thoughts
|
1
|
Resverlogix Corp.
|
Aug 01, 2017 03:07PM
|
|
Re: Statistical Considerations
|
1
|
Resverlogix Corp.
|
Mar 06, 2018 03:04PM
|
|
Question for the experts
|
1
|
Zenith Epigenetics
|
Oct 08, 2024 12:32PM
|
|
Re: A lesson on futility analyses from the CETP inhibitors
|
1
|
Resverlogix Corp.
|
May 10, 2017 03:30PM
|
|
Re: Removing plaque article
|
1
|
Resverlogix Corp.
|
Jun 27, 2017 02:37PM
|
|
Re: SH
|
1
|
Resverlogix Corp.
|
Dec 28, 2015 10:19AM
|
|
Re: AGM - Jan 7, 2016 - Details
|
1
|
Zenith Epigenetics
|
Jan 12, 2016 10:50PM
|
|
Consequences of BETonMACE Findings
|
1
|
Resverlogix Corp.
|
May 10, 2016 01:26PM
|
